BSE Live
Feb 01, 11:10Prev. Close
563.95
Open Price
563.45
Bid Price (Qty.)
556.85 (5)
Offer Price (Qty.)
559.15 (17)
NSE Live
Feb 01, 11:10Prev. Close
564.40
Open Price
557.05
Bid Price (Qty.)
557.75 (17)
Offer Price (Qty.)
558.05 (5)
| Cash Flow of Rossari Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 185.19 | 177.62 | 144.22 | 136.28 | 106.43 | |
| Net CashFlow From Operating Activities | 137.44 | 43.26 | 152.39 | 29.36 | 47.77 | |
| Net Cash Used In Investing Activities | -183.70 | -103.21 | -180.89 | -298.88 | -37.18 | |
| Net Cash Used From Financing Activities | 64.90 | 16.19 | 60.86 | 291.79 | -24.59 | |
| Foreign Exchange Gains / Losses | 0.38 | -0.25 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 19.03 | -44.03 | 32.36 | 22.27 | -14.00 | |
| Cash And Cash Equivalents Begin of Year | 25.17 | 69.20 | 37.48 | 15.21 | 29.21 | |
| Cash And Cash Equivalents End Of Year | 44.20 | 25.17 | 69.83 | 37.48 | 15.21 |
20.01.2026
Rossari Consolidated December 2025 Net Sales at Rs 581.68 crore, up 13.45% Y-o-Y
19.01.2026
Rossari Standalone December 2025 Net Sales at Rs 450.66 crore, up 22.37% Y-o-Y
16.10.2025
Rossari Consolidated September 2025 Net Sales at Rs 586.11 crore, up 17.61% Y-o-Y
16.10.2025
Rossari Standalone September 2025 Net Sales at Rs 419.51 crore, up 24.86% Y-o-Y